|
|
blood circulation
|
GO:0008015 |
195 |
0.933
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.900
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.899
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.865
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.864
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.863
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.817
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.803
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.794
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.790
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.772
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.743
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.677
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.673
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.669
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.654
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.632
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.627
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.614
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.602
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.602
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.554
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.508
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.491
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.487
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.477
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.474
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.456
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.447
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.444
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.443
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.433
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.412
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.368
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.357
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.353
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.347
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.334
|
|
|
|
directional locomotion
|
GO:0033058 |
3 |
0.325
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.320
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.317
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.317
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.310
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.295
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.289
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.287
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.286
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.286
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.285
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.267
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.262
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.248
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.238
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.231
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.228
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.228
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.224
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.218
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.216
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.210
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.203
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.202
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.201
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.198
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.194
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.185
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.181
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.180
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.178
|
|
|
|
regulation of membrane repolarization
|
GO:0060306 |
7 |
0.178
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.176
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.174
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.171
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.168
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.163
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.163
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.162
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.161
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.159
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.159
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.158
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.158
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.156
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.154
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.153
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.150
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.149
|
|
|
|
regulation of potassium ion transport
|
GO:0043266 |
16 |
0.147
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.147
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.145
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.144
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.143
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.141
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.138
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.137
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.136
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.133
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.132
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.131
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.129
|
|
|
|
positive regulation of transmembrane transport
|
GO:0034764 |
29 |
0.129
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.127
|
|
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
11 |
0.126
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.126
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.126
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.125
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.125
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.125
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.125
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.124
|
|
|
|
regulation of cardiac muscle contraction by calcium ion signaling
|
GO:0010882 |
9 |
0.124
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.122
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.122
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.120
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.118
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.117
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.117
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.116
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.114
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.113
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.113
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.113
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.112
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.112
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.111
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.110
|
|
|
|
cardiac conduction
|
GO:0061337 |
17 |
0.110
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.109
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.109
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.108
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.107
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.106
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.105
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.105
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.102
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.102
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.102
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.101
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.101
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.099
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.099
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.098
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.097
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.097
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.096
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.095
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.093
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.093
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.093
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.093
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.092
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.092
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.092
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.092
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.091
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.091
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.090
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.089
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.089
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.089
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.088
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.088
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.088
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.087
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.085
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.085
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.085
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.084
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.082
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.081
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.080
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.079
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.078
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.078
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.078
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.077
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.077
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.077
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.076
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.075
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.075
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.074
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.073
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.073
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.073
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.072
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.072
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.072
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.071
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.070
|
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.070
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.069
|
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.068
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.068
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.068
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.068
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.067
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.067
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.067
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.067
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.066
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.066
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.066
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.065
|
|
|
|
membrane repolarization
|
GO:0086009 |
7 |
0.065
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.065
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.064
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.064
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.064
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.064
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.063
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.063
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.063
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.063
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.063
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.062
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.062
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.061
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.061
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.061
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.061
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.061
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.060
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.060
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.060
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.060
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.060
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.060
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.060
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.060
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.059
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.059
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.059
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.058
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.058
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.058
|
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.057
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.057
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.057
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.057
|
|
|
|
regulation of relaxation of muscle
|
GO:1901077 |
8 |
0.057
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.056
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.056
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.055
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.055
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.054
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.054
|
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.054
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.054
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.054
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.054
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.054
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.054
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.053
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.053
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.053
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.052
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.052
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.052
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.052
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.052
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.051
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.051
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.051
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.051
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.051
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.051
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.051
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.050
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.050
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.050
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.050
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.050
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.049
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.049
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.049
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.049
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.049
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.049
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.048
|
|
|
|
forward locomotion
|
GO:0043056 |
1 |
0.048
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.047
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.047
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.047
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.047
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.046
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.046
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.046
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.046
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.046
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.046
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.045
|
|
|
|
response to camp
|
GO:0051591 |
14 |
0.045
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.045
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.045
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.045
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.045
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.045
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.044
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.044
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.044
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.044
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.044
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.044
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.044
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.043
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.043
|
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.043
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.043
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.043
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.043
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.042
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.042
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.041
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.041
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.041
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.041
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.041
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.041
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.040
|
|
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.040
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.040
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.040
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.040
|
|
|
|
negative regulation of transmembrane transport
|
GO:0034763 |
15 |
0.040
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.040
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.040
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.040
|
|
|
|
ventricular system development
|
GO:0021591 |
27 |
0.040
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.040
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.039
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.039
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.039
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.039
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.039
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.039
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.039
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.039
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.039
|
|
|
|
relaxation of cardiac muscle
|
GO:0055119 |
9 |
0.038
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.038
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.038
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.038
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.038
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.038
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.038
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.038
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.038
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.038
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.038
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.037
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.037
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.037
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.037
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.037
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.037
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.037
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.037
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.037
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.037
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.037
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.036
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.036
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.036
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.036
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.036
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.035
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.035
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.035
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.035
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.035
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.035
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.034
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.034
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.034
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.034
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.034
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.034
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.034
|
|
|
|
regulation of neurotransmitter transport
|
GO:0051588 |
35 |
0.034
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.033
|
|
|
|
regulation of potassium ion transmembrane transporter activity
|
GO:1901016 |
7 |
0.033
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.033
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.033
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.033
|
|
|
|
cell communication involved in cardiac conduction
|
GO:0086065 |
9 |
0.033
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.033
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.032
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.032
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.032
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.032
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.032
|
|
|
|
l glutamate uptake involved in synaptic transmission
|
GO:0051935 |
3 |
0.032
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.032
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.032
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.032
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.032
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.032
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.032
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.032
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.031
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.031
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.031
|
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.031
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.031
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.031
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.031
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.031
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.031
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.031
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.031
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.031
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.031
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.031
|
|
|
|
regulation of cardiac muscle cell contraction
|
GO:0086004 |
11 |
0.030
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.030
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.030
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.030
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.030
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.030
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.030
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.030
|
|
|
|
positive regulation of semaphorin plexin signaling pathway
|
GO:2001262 |
1 |
0.030
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.030
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.030
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.029
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.029
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.029
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.029
|
|
|
|
postganglionic parasympathetic nervous system development
|
GO:0021784 |
2 |
0.029
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.029
|
|
|
|
response to glucagon
|
GO:0033762 |
3 |
0.029
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.029
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.029
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.029
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.029
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.028
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.028
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.028
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
14 |
0.028
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.028
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.028
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.028
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.028
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.028
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.028
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.028
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.028
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.028
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.028
|
|
|
|
cardiac muscle cell action potential
|
GO:0086001 |
11 |
0.028
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
8 |
0.028
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.028
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.028
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.028
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.028
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.027
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.027
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.027
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.027
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.027
|
|
|
|
negative regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035359 |
3 |
0.027
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.027
|
|
|
|
atrioventricular node development
|
GO:0003162 |
3 |
0.027
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.027
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.026
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.026
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.026
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.026
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.026
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.026
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.026
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.026
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.026
|
|
|
|
insulin like growth factor receptor signaling pathway
|
GO:0048009 |
21 |
0.026
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.026
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.025
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.025
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.025
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.025
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.025
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.025
|
|